Tags

Type your tag names separated by a space and hit enter

Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study.
Antivir Ther. 2008; 13(3):389-97.AT

Abstract

BACKGROUND

To assess the prevalence of and factors associated with tobacco smoking and dependence in HIV patients.

METHODS

In a one-day cross-sectional national survey of a representative sample of 82 French units specialized in HIV-infected patient care, 727 consecutive outpatients were asked to complete a self-administered questionnaire, assessing smoking habits, dependence, cessation motivation, other substance abuse, sociocultural characteristics, life with HIV and its treatment. Smoking prevalence and dependence were assessed and compared with a representative sample of the general French population.

RESULTS

The questionnaire was completed by 593 (82%) patients: 12% were active or ex-intravenous drug users, 37% were homosexual men, and 43% were active smokers (compared with 31% in the French population) of whom 56% were classified as moderately or highly dependent. Fourteen percent of smokers were highly motivated and free of other substance abuse and of depressive symptoms. Smoking was independently associated with male sex (odds ratio [OR] = 2.38; 95% confidence interval [CI] 0.99-1.11), lower body mass index (OR 1.08; 95% Cl 1.14-1.03), smoking environment (OR 4.75; 95% Cl 3.02-7.49), excessive alcohol consumption (OR 2.50; 95% CI 1.20-5.23), illicit drug use (OR 2.43; 95% CI 1.41-4.19), HIV status disclosure to family (OR 1.81; 95% CI 1.16-2.85) and experience of rejection due to disclosure (OR 1.90; 95% CI 1.14-3.17). Disclosure and drug substitute usage were associated with high tobacco dependence.

CONCLUSIONS

Very few HIV smokers seem to be good candidates for a standard tobacco cessation program. Tobacco reduction or cessation strategies should be adapted to this population.

Authors+Show Affiliations

Inserm, Clinical Investigation Center 007, Inserm 738, Bichat, Paris, France xavier.duval@bch.aphp.frNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18572752

Citation

Duval, Xavier, et al. "Living With HIV, Antiretroviral Treatment Experience and Tobacco Smoking: Results From a Multisite Cross-sectional Study." Antiviral Therapy, vol. 13, no. 3, 2008, pp. 389-97.
Duval X, Baron G, Garelik D, et al. Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. Antivir Ther. 2008;13(3):389-97.
Duval, X., Baron, G., Garelik, D., Villes, V., Dupré, T., Leport, C., Lert, F., Peretti-Watel, P., Ravaud, P., & Spire, B. (2008). Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. Antiviral Therapy, 13(3), 389-97.
Duval X, et al. Living With HIV, Antiretroviral Treatment Experience and Tobacco Smoking: Results From a Multisite Cross-sectional Study. Antivir Ther. 2008;13(3):389-97. PubMed PMID: 18572752.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. AU - Duval,Xavier, AU - Baron,Gabriel, AU - Garelik,Daniel, AU - Villes,Virginie, AU - Dupré,Thierry, AU - Leport,Catherine, AU - Lert,France, AU - Peretti-Watel,Patrick, AU - Ravaud,Philippe, AU - Spire,Bruno, AU - ,, PY - 2008/6/25/pubmed PY - 2008/7/18/medline PY - 2008/6/25/entrez SP - 389 EP - 97 JF - Antiviral therapy JO - Antivir Ther VL - 13 IS - 3 N2 - BACKGROUND: To assess the prevalence of and factors associated with tobacco smoking and dependence in HIV patients. METHODS: In a one-day cross-sectional national survey of a representative sample of 82 French units specialized in HIV-infected patient care, 727 consecutive outpatients were asked to complete a self-administered questionnaire, assessing smoking habits, dependence, cessation motivation, other substance abuse, sociocultural characteristics, life with HIV and its treatment. Smoking prevalence and dependence were assessed and compared with a representative sample of the general French population. RESULTS: The questionnaire was completed by 593 (82%) patients: 12% were active or ex-intravenous drug users, 37% were homosexual men, and 43% were active smokers (compared with 31% in the French population) of whom 56% were classified as moderately or highly dependent. Fourteen percent of smokers were highly motivated and free of other substance abuse and of depressive symptoms. Smoking was independently associated with male sex (odds ratio [OR] = 2.38; 95% confidence interval [CI] 0.99-1.11), lower body mass index (OR 1.08; 95% Cl 1.14-1.03), smoking environment (OR 4.75; 95% Cl 3.02-7.49), excessive alcohol consumption (OR 2.50; 95% CI 1.20-5.23), illicit drug use (OR 2.43; 95% CI 1.41-4.19), HIV status disclosure to family (OR 1.81; 95% CI 1.16-2.85) and experience of rejection due to disclosure (OR 1.90; 95% CI 1.14-3.17). Disclosure and drug substitute usage were associated with high tobacco dependence. CONCLUSIONS: Very few HIV smokers seem to be good candidates for a standard tobacco cessation program. Tobacco reduction or cessation strategies should be adapted to this population. SN - 1359-6535 UR - https://www.unboundmedicine.com/medline/citation/18572752/Living_with_HIV_antiretroviral_treatment_experience_and_tobacco_smoking:_results_from_a_multisite_cross_sectional_study_ L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18572752/ DB - PRIME DP - Unbound Medicine ER -